Delivery of controlled-release system (s) |
| OF THE INVENTION The present invention is a method of making comestible units which disintegrate ... |
|
Composition for the treatment of cutaneous mycosis |
| I claim: 1. An antifungal powder composition for the treatment of cutaneous mycosis that consists ... |
|
Sustained release compositions for treating periodontal disease |
| OF THE INVENTION The essential as well as optional components of the compositions of this ... |
|
Prevention of crystal formation in toothpaste |
| OF THE INVENTION The dentifrices of the present invention include toothpastes, dental creams, or ... |
|
Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds |
| The present invention relates to chemiluminescence-directed antiviral activities of natural and ... |
|
Isoflavone compositions produced from legumes |
| In the broadest aspect of this invention there is provided processes for the production of ... |
|
Methods for inducing HIV-neutralizing antibodies |
| The invention claimed is: 1. A method for inducing antibodies neutralizing HIV primary isolates in ... |
|
Process for manufacturing a high protein food material |
| It is one of the objects of this invention to provide a food formulation that has a high-protein ... |
|
|
Method and apparatus for preparing a dairy product
| Details |
Inventors: ier, Erik; Andersen, Claus Michael;
Assignee: Chr. Hansen A/S (Horsholm, DK)
Primary Examiner: Wong; Leslie
Assistant Examiner:
Attorney, Agent or Firm: Hunton & Williams
A novel method and apparatus are disclosed for the manufacturing of dairy products. Also dairy products prepared by means of the disclosed method are comprised by the invention. The novel method makes use of preactivated cultures and results in a reduction of production time and costs in addition to a less complicated planning of the production work. |
|
DETAILED DESCRIPTION The residence time of the starter culture in the pre-incubator is preferably from about 10 to about 60 minutes, more preferably from about 10 to about 30 minutes and the temperature of the pre-incubator is from about 10 to about 50° C. , preferably about 20 to about 45° C. , more preferably from about 30 to about 35° C. , although this will depend on the characteristics of the microorganism in question. The aqueous suspension of dried or frozen starter culture is prepared at a temperature of about 20° C. or less, preferably about 15° C. or less. In one embodiment, the residence time of the starter culture in the pre-incubator is from 10 to 60 minutes, preferably from 10 to 30 minutes and the temperature of the pre-incubator is from 10 to 50° C. , preferably 20 to 45° C. , more preferably 30 to 35° C. , although, again, it will depend the characteristics of the microorganism in question. The mixing of the aqueous suspension of starter culture composition with the metered flow of milk may preferably be carried out in a mixer connected directly to the pre-incubator, at the preincubation temperature. The pre-incubator and preferably the mixer may be maintained at preincubation temperature by surrounding it with a heated fluid, for example a water bath at the appropriate temperature. The activated culture composition may be dispensed at intervals of, for example, five minutes or less, preferably two minutes or less. Using the method of the invention, it is possible at determined points of time to dose small cheese vats of 100 to 2000 liters, preferably 150 to 1500 liters, more preferably from 200 to 1000 liters with pre-activated starter culture composition (i. e. , the activated culture composition) in a very convenient manner. In order to more fully understand the principles and aspects of the present invention, a detailed description of a preferred embodiment thereof will be given below. An example of such a preferred embodiment of the invention is shown in the accompanying drawing, which is a schematic representation of an apparatus and method for preparing a dairy product, in accordance with the invention
|
| Related patents |
|
|
2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
"Lower alkyl of from one to four" or "ten carbons" in the present invention means methyl, ethyl, propyl, butyl or further pentyl, hexyl, heptyl or the like and isomers ...
|
|
|
1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
What is claimed is: 1. A compound of Formula I ##STR7## wherein R.sup.1 is alkylsulfonyl or sulfamyl; wherein R.sup.2 is aryl; wherein R.sup.2 is optionally substituted ...
|
|
|
N-benzyl-3-indoleacetic acids as antiinflammatory drugs
OF THE INVENTION The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration ...
|
|
|
Method for chemoprevention of prostate cancer
This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of a chemopreventive ...
|
|
|
Method for chemoprevention of prostate cancer
This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of an antiestrogen to ...
|
|
|
Method for chemoprevention of prostate cancer
This invention relates to the chemoprevention of prostate cancer and, more particularly, to a method of suppressing or inhibiting latent prostate cancer comprising the ...
|
|
|
Food additive composition
OF THE PREFERRED EMBODIMENTS The present invention is directed to food supplement compositions containing a wide variety of beans, grains, vitamins, herbs, and spices ...
|
|
|
Method for chemoprevention of prostate cancer
This invention related to a method for preventing prostate carcinogenesis of a subject comprising: administering to a mammalian subject, a pharmaceutical preparation ...
|
|
|
Placental alkaline phosphatase to control diabetes
In one embodiment, the present invention provides a method of reducing plasma glucose level in a mammal, comprising the step of administering a therapeutically effective ...
|
|
|
Process for producing malt alcoholic drink
The invention claimed is: 1. A method of producing a malt alcohol beverage, comprising: removing through adsorption at least a part of rough flavor components from malt, ...
|
|
|